ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      87.33
      0.48%
      Bitcoin
      58,165.77
      -3.32%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Enanta Pharmaceuticals Inc (ENTA)

      7. Enanta Pharmaceuticals Inc (ENTA) News

      ENTA

      Enanta Pharmaceuticals (ENTA)

      Enanta Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ENTA
      DateTimeSourceHeadlineSymbolCompany
      02/01/20168:00AMBusiness WireEnanta Pharmaceuticals to Present at the LEERINK Partners 5th Annual Global Healthcare ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/28/20163:49PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/28/20168:00AMBusiness WireEnanta Pharmaceuticals to Host Conference Call on February 8 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Firs...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/25/201611:45AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/20/20164:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/13/20164:27PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/11/20164:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/11/20164:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/11/20164:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/11/20168:00AMBusiness WireEnanta Pharmaceuticals Announces New R&D Initiatives in Hepatitis B Virus & Respiratory Syncytial Virus & Plan to Provide Dat...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/11/20167:10AMBusiness WireEnanta Pharmaceuticals Announces That AbbVie Has Initiated Enrollment of Six Global Phase 3 Clinical Studies of Its Once-Dail...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/11/20167:00AMPR Newswire (US)AbbVie Initiates Enrollment of Six Global Phase 3 Clinical Studies for Once-Daily, Pan-Genotypic Hepatitis C RegimenNASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/07/20169:09AMBusiness WireEnanta Pharmaceuticals Announces the U.S. FDA Grants Priority Review to AbbVie’s Supplemental New Drug Application for VIEK...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/07/20169:00AMPR Newswire (US)U.S. FDA Grants Priority Review to AbbVie for Supplemental New Drug Application for VIEKIRA PAK® (ombitasvir, paritaprevir, ...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/05/20166:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      01/04/20168:00AMBusiness WireEnanta Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference Presentation to be Webcast on January ...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      12/14/20158:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      12/14/20158:00AMBusiness WireEnanta Pharmaceuticals Announces the Election of Bruce L.A. Carter, Ph.D. as Non-Executive Chairman of the Board of DirectorsNASDAQ:ENTAEnanta Pharmaceuticals Inc
      12/11/20155:14PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      12/02/20158:07AMBusiness WireEnanta Pharmaceuticals Announces FDA Acceptance of AbbVie’s New Drug Application for a Once-Daily Formulation of VIEKIRA PA...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      12/02/20158:00AMPR Newswire (US)AbbVie Announces FDA Acceptance of New Drug Application for a Once-Daily Formulation of VIEKIRA PAK® (ombitasvir, paritaprev...NASDAQ:ENTAEnanta Pharmaceuticals Inc
      11/25/20155:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      11/24/20156:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      11/24/20156:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      11/24/20156:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      11/24/20156:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      11/24/20156:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      11/24/20156:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      11/23/20154:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENTAEnanta Pharmaceuticals Inc
      11/23/20154:01PMBusiness WireEnanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2015NASDAQ:ENTAEnanta Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ENTA